Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 143K 128K 118K 107K 200K 13.61M 204K 1.41M 565K 7.16M 538K 527K 22.58M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.55M 18.91M 17.13M 32.02M 2.18B 32.62M 225M 90.5M 1.15B 86.12M 84.29M 3.61B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/2004 | |
| Chief Tech/Sci/R&D Officer | 61 | 03/04/2006 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 24/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 01/01/1992 | |
Jeffrey Peterson
CHM | Chairman | 70 | 08/08/2012 |
Michael Urdea
BRD | Director/Board Member | 73 | 08/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.32% | -0.08% | +21.15% | +52.91% | 258B | |
| -1.82% | -1.70% | +6.99% | +18.68% | 163B | |
| +0.99% | -2.65% | -19.22% | +58.21% | 150B | |
| +3.42% | -4.93% | -56.05% | -17.49% | 60.84B | |
| +1.36% | +3.07% | -10.71% | -8.02% | 53.31B | |
| +2.24% | +4.27% | +13.68% | +44.10% | 53.03B | |
| -0.46% | -2.32% | +6.18% | +63.66% | 50.67B | |
| -1.80% | -1.60% | +19.67% | +65.74% | 49.3B | |
| -2.70% | -0.49% | +31.30% | +84.90% | 45.46B | |
| Average | +0.03% | -0.30% | +1.44% | +40.30% | 98.22B | |
| Weighted average by Cap. | -0.46% | +0.15% | +3.59% | +41.41% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.55M 1.42M 1.29M 2.41M 164M 2.46M 16.99M 6.82M 86.38M 6.49M 6.35M 272M | 1.98M 1.77M 1.63M 1.48M 2.76M 188M 2.81M 19.43M 7.8M 98.78M 7.42M 7.26M 312M |
| Net income | -16.08M -14.4M -13.24M -12M -22.43M -1.53B -22.85M -158M -63.4M -803M -60.33M -59.05M -2.53B | -29.31M -26.25M -24.15M -21.88M -40.9M -2.78B -41.67M -288M -116M -1.46B -110M -108M -4.62B |
| Net Debt | 20.53M 18.38M 16.91M 15.32M 28.64M 1.95B 29.18M 202M 80.95M 1.03B 77.03M 75.39M 3.23B | 22.8M 20.42M 18.79M 17.02M 31.82M 2.17B 32.41M 224M 89.94M 1.14B 85.58M 83.76M 3.59B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
